Cargando…

Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis

BACKGROUND: Little data exist on the use of direct oral anticoagulant (DOAC) factor Xa inhibitors for submassive pulmonary embolism (PE) after catheter-directed thrombolysis (CDT). The objective of this evaluation was to determine whether the transition from parenteral anticoagulation to DOACs for s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Groetzinger, Lara M., Miller, Taylor J., Rivosecchi, Ryan M., Smith, Roy E., Gladwin, Mark T., Rivera-Lebron, Belinda N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714714/ https://www.ncbi.nlm.nih.gov/pubmed/29455567 http://dx.doi.org/10.1177/1076029618755311

Ejemplares similares

Outcomes of catheter-directed thrombolysis vs. standard medical therapy in patients with acute submassive pulmonary embolism
por: D’Auria, Stephen, et al.
Publicado: (2020)

Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism in the Third Trimester of Pregnancy
por: Compadre, Amanda J., et al.
Publicado: (2020)

Catheter-directed therapy for submassive pulmonary embolism after unsuccessful systemic thrombolysis
por: Dong, Chang, et al.
Publicado: (2017)

Low-dose thrombolysis for submassive pulmonary embolism
por: Yilmaz, Emine Serap, et al.
Publicado: (2021)

Catheter-directed Thrombolysis versus Systemic Anticoagulation for Submassive Pulmonary Embolism: A Meta-Analysis
por: Siordia, Juan Arturo, et al.
Publicado: (2022)

Safety of apixaban and rivaroxaban compared to warfarin after cardiac surgery
por: Naik, Kushal D., et al.
Publicado: (2022)

Clinical outcomes of submassive pulmonary embolism thrombolysis—an Indian experience
por: Rehman, Nadeem U., et al.
Publicado: (2020)

Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism
por: Patel, Darshan C., et al.
Publicado: (2019)

Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
por: Wisløff, Torbjørn, et al.
Publicado: (2014)

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
por: Chan, Yi‐Hsin, et al.
Publicado: (2018)

Feasibility and safety of catheter-directed thrombolysis via superficial cubital vein for the treatment of acute massive and submassive pulmonary embolism
por: Giunio, Lovel, et al.
Publicado: (2021)

Submassive Pulmonary Embolism Treated With Catheter-Directed Thrombolysis in Resource-Limited Setting: A Case Report and Review of Literature
por: Gurjar, Hitesh, et al.
Publicado: (2022)

Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism
por: Cao, Yaoqian, et al.
Publicado: (2014)

A systematic review for the role of systemic thrombolysis in intermediate-risk (submassive) pulmonary embolism
por: Seif, Mohamed Ahmed
Publicado: (2020)

Comparative effectiveness of dabigatran, rivaroxaban, apixaban and warfarin in the management of patients with non-valvular atrial fibrillation
por: Pink, Joshua, et al.
Publicado: (2013)

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
por: Martinez, Brandon K., et al.
Publicado: (2018)

Impact of Oral Thrombolysis After Catheter-based Thrombectomy in Acute and Subacute Submassive Pulmonary Thromboembolism
por: Ahmed, Khurshid, et al.
Publicado: (2015)

Impact of introducing guidelines for thrombolysis of submassive pulmonary embolism at a large UK teaching hospital
por: Misselbrook, GP
Publicado: (2015)

Unloading of Right Ventricle and Clinical Improvement after Ultrasound-Accelerated Thrombolysis in Patients with Submassive Pulmonary Embolism
por: Jain, Sachin Kumar Amruthlal, et al.
Publicado: (2014)

Ultrasound-Facilitated Catheter-Directed Thrombolysis via Dual Right Upper Extremity Venous Access Into the Basilic Vein in a Case of Submassive Pulmonary Embolism
por: Elkhouly, Ahmed, et al.
Publicado: (2021)

Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study
por: Kjerpeseth, Lars J., et al.
Publicado: (2019)

Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
por: Li, Wei-Jia, et al.
Publicado: (2021)

Thrombolytic therapy in submassive pulmonary embolism
por: Özlek, Eda, et al.
Publicado: (2017)

Retraction: Ultrasound-Facilitated Catheter-Directed Thrombolysis via Dual Right Upper Extremity Venous Access Into the Basilic Vein in a Case of Submassive Pulmonary Embolism
por: Elkhouly, Ahmed, et al.
Publicado: (2021)

Management of Submassive Bilateral Pulmonary Embolism in an Adolescent Female
por: Lim, Adeline Yi Ling, et al.
Publicado: (2021)

Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups
por: Gómez-Outes, Antonio, et al.
Publicado: (2013)

Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban
por: Lip, Gregory Y. H., et al.
Publicado: (2018)

Measurement of rivaroxaban and apixaban in serum samples of patients
por: Harenberg, Job, et al.
Publicado: (2014)

Systemic thrombolysis for acute submassive pulmonary embolism after laparoscopic Roux-en-Y bypass: A case report
por: Brañes, Alejandro, et al.
Publicado: (2019)

Submassive Pulmonary Embolism and Left Atrial Thrombus
por: Konik, Ewa, et al.
Publicado: (2018)

Successful treatment of submassive pulmonary embolism with right ventricle strain using ultrasound-assisted thrombolysis with urokinase: a case report
por: Al-Terki, Hani, et al.
Publicado: (2023)

Successful low-dose thrombolysis of submassive pulmonary embolus in a pregnant patient
por: Dhutia, Harshil, et al.
Publicado: (2014)

Submassive Central Saddle and Extensive Bilateral Pulmonary Embolism Presenting as Syncope Treated with Catheter-directed Therapy
por: Andrusaitis, Jessica, et al.
Publicado: (2018)

Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
por: Castillo, Renee, et al.
Publicado: (2020)

How the Results of a Randomized Trial of Catheter-Directed Thrombolysis versus Anticoagulation Alone for Submassive Pulmonary Embolism Would Affect Patient and Physician Decision Making: Report of an Online Survey
por: Taslakian, Bedros, et al.
Publicado: (2019)

Thrombolytic and anticoagulant therapy for acute submassive pulmonary embolism
por: FEI, JIANWEN, et al.
Publicado: (2014)

Submassive Pulmonary Embolism Complicating Small Bowel Obstruction
por: Sagalov, Andrew, et al.
Publicado: (2021)

Submassive Pulmonary Embolism: Current Perspectives and Future Directions
por: Nguyen, Phillip C., et al.
Publicado: (2021)

Right Ventricle Thrombus in the Setting of Submassive Pulmonary Embolism
por: Patel, Rutul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8s8k86svglngc94fhuf7pmqnpi